Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515567 · ClinicalTrials.gov registry record
Explanted Lung Tissues With Pulmonary Fibrosis
A clinical trial of Pulmonary Fibrosis, sponsored by University of Chicago.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT00515567: Recruiting study of Pulmonary Fibrosis, sponsored by University of Chicago.
NCT00515567 is a study of Pulmonary Fibrosis that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 90 participants, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00515567, a study of Pulmonary Fibrosis, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.
Conditions Studied
Study Locations (1)
Illinois
- The University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2006-02 |
| Est. Completion | 2026-12 |
What NCT00515567 shows while recruiting
NCT00515567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00515567 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00515567 about?
NCT00515567 is a clinical study titled "Explanted Lung Tissues With Pulmonary Fibrosis". The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.
What is the current status of trial NCT00515567?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2006-02. Estimated completion is 2026-12.
What conditions does trial NCT00515567 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis.
Who is sponsoring clinical trial NCT00515567?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00515567 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00515567's enrollment target sits among peer trials
90 13th of 22 higher than 10 of 22 other Pulmonary Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia